Abstract
Ovarian cancer is recognized with high mortality due to asymptomatic nature of the disease and difficulties in diagnosing early stage of the cancer. The present study evaluates the use of differential scanning calorimetry (DSC) in differentiating the severity of ovarian cancer from healthy women. 47 diseased women were subdivided into four stages with respect to clinical relevance and severity. Stages I–II were regarded as early stages and stages III–IV were regarded as advanced stages. The two average transition temperatures (T m ) increased with disease severity from 64.84 and 70.32 °C (healthy) to 68.46 and 75.24 °C (stage IV), respectively. T m were increased depending on clinical groups. In addition, the change in heat capacity was also dependent on the disease severity. To further support and investigate the nature of the proposed interactions, matrix assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis is employed. The results suggest the differences in peptide expression between early and advanced stage of ovarian cancer, affected abundant proteins in plasma. The combined DSC and MS approach was supportive in identifying a unique signature of ovarian cancer stages, and demonstrates the potential of DSC as a complementary diagnostic tool in the evaluation of early stage ovarian cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmed N, Oliva KT, Barker G, Hoffmann P, Reeve S, Smith IA, Quinn MA, Rice GE (2005) Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer. Proteomics 5:4625–4636
Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70:209–262
Chagovetz AA, Jensen RL, Recht L, Glantz M, Chagovetz AM (2011) Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme. J Neuro-oncol 105:499–506
Chertov O, Biragyn A, Kwak LW, Simpson JT, Boronina T, Hoang VM, Prieto DA, Conrads TP, Veenstra TD, Fisher RJ (2004) Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry. Proteomics 4:1195–1203
Craig WY, Ledue TB, Ritchie RF (2001) Plasma proteins: clinical utility and interpretation. Foundation for Blood Research. http://www.fbr.org/Otherpages/TechnicalBrochures.aspx
Dalton WS, Friend SH (2006) Cancer biomarkers—an invitation to the table. Science 312:1165–1168
Duffy M, Bonfrer J, Kulpa J, Rustin G, Soletormos G, Torre G, Tuxen M, Zwirner M (2005) CA125 in ovarian cancer: European Group on tumor markers guidelines for clinical use. Int J Gynecol Cancer 15:679–691
Ebert MP, Korc M, Malfertheiner P, Rocken C (2006) Advances, challenges, and limitations in serum-proteome-based cancer diagnosis. J Proteome Res 5:19–25
Ferencz A, Lőrinczy D, Fekecs T (2011) Differential scanning calorimetry, as a new method to monitor human plasma in melanoma patients with regional lymph node or distal metastases. In: Xi Y (ed) Skin cancer overview. InTech, Rijeka, pp 141–152
Garbett NC, Miller JJ, Jenson AB, Chaires JB (2007) Calorimetric analysis of the plasma proteome. Semin Neephrol 27:621–626
Garbett NC, Miller JJ, Jenson AB, Chaires JB (2008) Calorimetry outside the box: a new window into the plasma proteome. Biophys J 94:1377–1383
Garbett NC, Mekmaysy CS, Helm CW, Jenson AB, Chaires JB (2009) Differential scanning calorimetry of blood plasma for clinical diagnosis and monitoring. Exp Mol Pathol 86:186–191
Garbett NC, Merchant ML, Chaires JB, Klein JB (2013) Calorimetric analysis of the plasma proteome: identification of type 1 diabetes patients with early renal function decline. Biochim Biophys Acta 1830:4675–4680
Garbett NC, Merchant ML, Helm CW, Jenson AB, Klein JB, Chaires JB (2014) Detection of cervical cancer biomarker patterns in blood plasma and urine by differential scanning calorimetry and mass spectrometry. PLoS ONE 9:e84710. doi:10.1371/journal.pone.0084710
Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9:69
Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313:670–673
Kim NA, Lim DG, Lim JY, Kim KH, Jeong SH (2014) Comprehensive evaluation of etanercept stability in various concentrations with biophysical assessment. Int J Pharm 460:108–118
Lee JH, Kim KH, Park JW, Chang HJ, Kim BC, Kim SY, Kim KG, Lee ES, Kim DY, Oh JH, Yoo BC, Kim IH (2014) Low-mass-ion discriminant equation: a new concept for colorectal cancer screening. Int J Cancer 134:1844–1853
Michnik A, Michalik K, Kluczewska A, Drzazga Z (2005) Comparative DSC study of human and bovine serum albumin. J Therm Anal Calorim 84:113–117
Michnik A, Drzazga Z, Michalik K, Barczyk A, Santura I, Sozańska E, Pierzchała W (2010) Differential scanning calorimetry study of blood serum in chronic obstructive pulmonary disease. J Therm Anal Calorim 102:57–60
Mor G, Visintin I, Lai Y, Zhao H, Schwartz P, Rutherford T, Yue L, Bray-Ward P, Ward DC (2005) Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci USA 102:7677–7682
Omtvedt LA, Royle L, Husby G, Sletten K, Radcliffe CM, Harvey DJ, Dwek RA, Rudd PM (2006) Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthritis Rheum 54:3433–3440
Rosenblatt KP, Bryant-Greenwood P, Killian JK, Mehta A, Geho D, Espina V, Petricoin EF 3rd, Liotta LA (2004) Serum proteomics in cancer diagnosis and management. Annu Rev Med 55:97–112
Saldova R, Royle L, Radcliffe CM, Hamid UMA, Evans R, Arnold JN, Banks RE, Hutson R, Harvey DJ, Antrobus R (2007) Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 17:1344–1356
Todinova S, Krumova S, Gartcheva L, Robeerst C, Taneva SG (2011) Microcalorimetry of blood serum proteome: a modified interaction network in the multiple myeloma case. Anal Chem 83:7992–7998
Todinova S, Krumova S, Kurtev P, Dimitrov V, Djongov L, Dudunkov Z, Taneva SG (2012) Calorimetry-based profiling of blood plasma from colorectal cancer patients. Biochim Biophys Acta 1820:1879–1885
Zapf I, Fekecs T, Ferencz A, Tizedes G, Pavlovics G, Kálmán E, Lőrinczy D (2011) DSC analysis of human plasma in breast cancer patients. Thermochim Acta 524:88–91
Acknowledgments
This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. (HI12C0050).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Kim, N.A., Jin, J.H., Kim, KH. et al. Investigation of early and advanced stages in ovarian cancer using human plasma by differential scanning calorimetry and mass spectrometry. Arch. Pharm. Res. 39, 668–676 (2016). https://doi.org/10.1007/s12272-016-0722-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-016-0722-z